 |
 |
||||||
 |
Commentaires de nos clients |
Votre panier
$0.00 (0 articles)
| |||||
Générique Celecoxib - Celebrex
| ||||||
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth.
- Sildenafil citrate and pulmonary arterial hypertension
Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure.
- Fruit and vegetables do not reduce overall cancer risk, review concludes
Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people.
- Common painkillers could be linked to male reproductive disorder
The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study.
Notre page de facturation est certifiée par:
- Decreased Risk for Upper, Lower GI Events With COX-2 Inhibitor Compared With ... - Pain Medicine News
Decreased Risk for Upper, Lower GI Events With COX-2 Inhibitor Compared With .
- Nano-Formulated Diclofenac Found Effective in Phase 2 Trial - Medscape
Nano-Formulated Diclofenac Found Effective in Phase 2 TrialMedscapeThey randomly assigned 51 patients to a placebo, 49 patients to 18 mg of nano-formulated diclofenac, 51 patients to 35 mg of nano-formulated diclofenac, and 51 patients to 400 mg of celecoxib.
- Nano-Formulated Lower-Dose Oral Diclofenac Provides Acute Pain Relief - Monthly Prescribing Reference
Nano-Formulated Lower-Dose Oral Diclofenac Provides Acute Pain ReliefMonthly Prescribing Reference“Subjects assessed baseline pain intensity before receiving a single dose of nano-formulated lower dose diclofenac 18mg or 35mg, celecoxib 400mg, or placebo, and pain intensity and pain relief from 15 minutes through 12 hours,” Dr.
- Tanezumab has advantages over Celebrex for osteoarthritic pain; report - The Pharma Letter
Tanezumab has advantages over Celebrex for osteoarthritic pain; reportThe Pharma LetterClinical data and the opinions of interviewed thought leaders indicate that Pfizer's investigational compound tanezumab has advantages on this attribute over Pfizer's Celebrex (celecoxib), the sales-leading agent for osteoarthritic pain.
- Generic Lipitor and charges hurt Pfizer profits - Pharma Times
Globe and MailGeneric Lipitor and charges hurt Pfizer profitsPharma TimesNet income fell 19% to $1.
|
| Copyright © 2005-2010 Canadian Pharmacy Online Canada Pharmacy, Canadian Pharmacy. |